B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ABCB1

MOLECULAR TARGET

ATP binding cassette subfamily B member 1

UniProt: P08183NCBI Gene: 5243145 compounds

ABCB1 (ATP binding cassette subfamily B member 1) is targeted by 145 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ABCB1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Reserpine2.8316
2Quinidine2.4811
3Astemizole Antihistamine drug now withdrawn from1.795
4Clotrimazole1.795
5Testosterone1.614
6Emetine1.614
7Progesterone1.393
8Simvastatin1.393
9Carvedilol1.393
10Colchicine1.393
11Digitoxigenin 3 beta,14-Dihydroxy-5 beta-card-20(22)enolide.1.393
12Miconazole1.393
13Nocodazole Nocodazole is1.393
14Podophyllotoxin1.393
15Ritonavir1.393
16egcg1.102
172-Methoxyestradiol1.102
18Methotrexate1.102
19Anisomycin1.102
20Azathioprine1.102
21Bromocriptine1.102
22Calcimycin1.102
23cycloheximide1.102
24Danazol1.102
25Daunorubicin1.102
26Delavirdine1.102
27Demecolcine1.102
28Digoxigenin 3 beta,12 beta,14-Trihydroxy-5 beta-card-20(22)-enolide.1.102
29Digoxin1.102
30Equilin1.102
31Levonorgestrel1.102
32Lovastatin1.102
33Nandrolone C18 steroid with androgenic and anabolic properties. It is generally prepared from alkyl ethers of ESTRADIOL to resemble TESTOSTERONE but less1.102
34Niclosamide1.102
35Norgestrel1.102
36Nortriptyline1.102
37streptonigrin1.102
38Strophanthidin 3 beta,5,14-Trihydroxy-19-oxo-5 beta-card-20(22)-enolide.1.102
39Tubercidin1.102
40tyrphostin 91.102
41Valinomycin1.102
42vinblastine sulfate1.102
43Vincristine1.102
44Apigenin 5,7,4'-trihydroxy-flavone,0.691
45Budesonide0.691
46chrysin0.691
47Kaempferols0.691
48Thyroxine0.691
49Piracetam0.691
50Quercetin0.691

Showing top 50 of 145 compounds. Use the BiohacksAI search to explore all ABCB1 modulators.

About ABCB1 as a Drug Target

ABCB1 (ATP binding cassette subfamily B member 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 145 compounds with documented ABCB1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ABCB1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.